Splenic vein-inferior mesenteric vein anastomosis to lessen left-sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection

Archives of Surgery

Volumn 146, Issue 12, 2011, Pages 1375-1381

  Ferreira, Nélio ^a   Oussoultzoglou, Elie ^a   Fuchshuber, Pascal ^b   Ntourakis, Dimitrios ^a   Narita, Masato ^a   Rather, Mudassir ^a   Rosso, Edoardo ^a   Addeo, Pietro ^a   Pessaux, Patrick ^a   Jaeck, Daniel ^a   Bachellier, Philippe ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PORTAL HYPERTENSION; PORTAL VEIN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SPLEEN SIZE; SPLENIC VEIN INFERIOR MESENTERIC VEIN ANASTOMOSIS; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; TREATMENT OUTCOME; VASCULAR SURGERY; VEIN ANASTOMOSIS; VEIN BLOOD FLOW;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION, PORTAL; HYPERTROPHY; MALE; MESENTERIC VEINS; MIDDLE AGED; NEOPLASM STAGING; ORGAN SIZE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PLATELET COUNT; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPLEEN; SPLENIC VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84555187173     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.688     Document Type: Article

References (35)

1. Hartel M, Wente MN, Di Sebastiano P, Friess H, Büchler MW. The role of extended resection in pancreatic adenocarcinoma: is there good evidence-based justification? Pancreatology. 2004;4(6):561-566. (Pubitemid 40091408)
2. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91(5):586-594. (Pubitemid 38624667)
3. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13(8):1035-1046. (Pubitemid 44337962)
4. Tseng JF, Tamm EP, Lee JE, Pisters PW, Evans DB. Venous resection in pancreatic cancer surgery. Best Pract Res Clin Gastroenterol. 2006;20(2):349-364.
5. Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 3: update on 5-year survival. J Gastrointest Surg. 2005;9(9):1191-1206. (Pubitemid 41751111)
6. Glanemann M, Shi B, Liang F, et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol. 2008;6:123-133.
7. Misuta K, Shimada H, Miura Y, et al. The role of splenomesenteric vein anastomosis after division of the splenic vein in pancreatoduodenectomy. J Gastrointest Surg. 2005;9(2):245-253. (Pubitemid 40202983)
8. Tamura K, Sumi S, Koike M, Yano S, Nagami H, Nio Y. A splenic-inferior mesenteric venous anastomosis prevents gastric congestion following pylorus preserving pancreatoduodenectomy with extensive portal vein resection for cancer of the head of the pancreas. Int Surg. 1997;82(2):155-159.
9. Sakaguchi T, Suzuki S, Morita Y, et al. Analysis of anatomic variants of mesenteric veins by 3-dimensional portography using multidetector-row computed tomography. Am J Surg. 2010;200(1):15-22.
10. Pessaux P, Regenet N, Arnaud JP. Resection of the retroportal pancreatic lamina during a cephalic pancreaticoduodenectomy: first dissection of the superior mesenteric artery. Ann Chir. 2003;128(9):633-636. (Pubitemid 37533378)
11. Smoot RL, Christein JD, Farnell MB. Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg. 2006;10(10):1371-1375. (Pubitemid 44920299)
12. Fujisaki S, Tomita R, Fukuzawa M. Utility of mobilization of the right colon and the root of the mesentery for avoiding vein grafting during reconstruction of the portal vein. J Am Coll Surg. 2001;193(5):576-578. (Pubitemid 33043464)
13. Bachellier P, Nakano H, Oussoultzoglou PD, et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg. 2001;182(2):120-129. (Pubitemid 32907346)
14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213. (Pubitemid 38963009)
15. Bassi C, Dervenis C, Butturini G, et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8-13. (Pubitemid 40933766)
16. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761-768. (Pubitemid 350018837)
17. Roberts N, Puddephat MJ, McNulty V. The benefit of stereology for quantitative radiology. Br J Radiol. 2000;73(871):679-697. (Pubitemid 30614222)
18. Dello SA, van Dam RM, Slangen JJ, et al. Liver volumetry plug and play: do it yourself with ImageJ. World J Surg. 2007;31(11):2215-2221. (Pubitemid 47620219)
19. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery. 1995;117(1):50-55.
20. Reddy SK, Tyler DS, Pappas TN, Clary BM. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007;12(6):654-663. (Pubitemid 47036202)
21. Bahra M, Neumann U. Surgical techniques for resectable pancreatic cancer. Recent Results Cancer Res. 2008;177:29-38.
22. Schäfer M, Müllhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg. 2002;236(2):137-148. (Pubitemid 34809532)
23. Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998;85(5):611-617. (Pubitemid 28247531)
24. Nakao A, Takeda S, Sakai M, et al. Extended radical resection vs standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas. 2004;28(3):289-292. (Pubitemid 38437325)
25. Nakao A, Takeda S, Inoue S, et al. Indications and techniques of extended resection for pancreatic cancer. World J Surg. 2006;30(6):976-984.
26. Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol. 2004;182(2):419-425. (Pubitemid 38116586)
27. Cusack JC Jr, Fuhrman GM, Lee JE, Evans DB. Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg. 1994;168(4):352-354. (Pubitemid 24313212)
28. Fortner JG. Technique of regional subtotal and total pancreatectomy. Am J Surg. 1985;150(5):593-600. (Pubitemid 16199777)
29. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8(8):935-950. (Pubitemid 39600636)
30. Maillard JN, Le Baleur A, Hay JM, Desvignes G, Rodary M. Resections of the portal vein: anatomical basis, clinical results. Chirurgie. 1975;101(11):871-876.
31. Carrère N, Sauvanet A, Goere D, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006;30(8):1526-1535. (Pubitemid 44421258)
32. Köklü SE, Yüksel OS, Arhan ME, et al. Report of 24 left-sided portal hypertension cases: a single-center prospective cohort study. Dig Dis Sci. 2005;50(5):976-982.
33. Itzchak Y, Glickman MG. Splenic vein thrombosis in patients with a normal size spleen. Invest Radiol. 1977;12(2):158-163. (Pubitemid 8100618)
34. Dib N, Konate A, Oberti F, Calès P. Non-invasive diagnosis of portal hypertension in cirrhosis: application to the primary prevention of varices. Gastroenterol Clin Biol. 2005;29(10):975-987. (Pubitemid 41585901)
35. Overman MJ, Maru DM, Charnsangavej C, et al. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010;28(15):2549-2555.